SG11201703193XA - Treatment for depression and depressive disorders - Google Patents

Treatment for depression and depressive disorders

Info

Publication number
SG11201703193XA
SG11201703193XA SG11201703193XA SG11201703193XA SG11201703193XA SG 11201703193X A SG11201703193X A SG 11201703193XA SG 11201703193X A SG11201703193X A SG 11201703193XA SG 11201703193X A SG11201703193X A SG 11201703193XA SG 11201703193X A SG11201703193X A SG 11201703193XA
Authority
SG
Singapore
Prior art keywords
depression
treatment
depressive disorders
depressive
disorders
Prior art date
Application number
SG11201703193XA
Inventor
Luis Vitetta
Samantha Coulson
Sean Hall
Original Assignee
Medlab Ip Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014904306A external-priority patent/AU2014904306A0/en
Application filed by Medlab Ip Pty Ltd filed Critical Medlab Ip Pty Ltd
Publication of SG11201703193XA publication Critical patent/SG11201703193XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201703193XA 2014-10-28 2015-10-28 Treatment for depression and depressive disorders SG11201703193XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2014904306A AU2014904306A0 (en) 2014-10-28 Treatment for depression and depressive disorders
PCT/AU2015/050673 WO2016065419A1 (en) 2014-10-28 2015-10-28 Treatment for depression and depressive disorders

Publications (1)

Publication Number Publication Date
SG11201703193XA true SG11201703193XA (en) 2017-05-30

Family

ID=55856280

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703193XA SG11201703193XA (en) 2014-10-28 2015-10-28 Treatment for depression and depressive disorders

Country Status (7)

Country Link
US (1) US11135181B2 (en)
EP (1) EP3212191B1 (en)
AU (1) AU2015337800B2 (en)
CA (1) CA2964971C (en)
ES (1) ES2929100T3 (en)
SG (1) SG11201703193XA (en)
WO (1) WO2016065419A1 (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
EP3466435B1 (en) * 2016-05-31 2023-08-16 Morinaga Milk Industry Co., Ltd. Brain function improving agent
IT201600084470A1 (en) * 2016-08-10 2018-02-10 Probiotical Spa Composition for use in the treatment of major depressive disorder
KR20180019474A (en) * 2016-08-16 2018-02-26 주식회사 엠디헬스케어 Composition for Prevention or Treatment of Mental Disorders Comprising Extracellular Vesicles Derived from Lactic acid bacteria
KR102591869B1 (en) * 2017-06-02 2023-10-19 유니버시티 오브 오타고 Use of lactic acid bacteria to treat or prevent at least one of postpartum depression and postpartum anxiety
EP3664894B1 (en) 2017-08-11 2021-09-29 Biocodex Saccharomyces boulardii for the treatment of mood disorders
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
WO2019083297A1 (en) * 2017-10-26 2019-05-02 주식회사 네비팜 Medicinal composition for preventing or treating liver diseases
KR20200112840A (en) * 2017-12-19 2020-10-05 듀폰 뉴트리션 바이오사이언시즈 에이피에스 Probiotics for cognitive and mental health
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
RU2020122896A (en) 2017-12-19 2022-01-20 Пробиотикал С.п.А. COMPOSITION FOR USE IN THE TREATMENT AND/OR IMPROVEMENT OF SLEEP AND MOOD DISORDERS
CN108079023B (en) * 2018-01-04 2020-10-09 诺佰克（武汉）生物科技有限公司 Application of lactobacillus equi ZW3 in preparation of medicines for preventing or improving mental problems caused by stress
WO2019136391A1 (en) * 2018-01-05 2019-07-11 Human Longevity, Inc. Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla
RU2764639C1 (en) 2018-02-02 2022-01-19 Кобиолабс, Инк. Lactobacillus plantarum strain kbl396 and application thereof
EP3768287A2 (en) * 2018-03-22 2021-01-27 Adare Pharmaceuticals SAS New use of microbiological compositions
BR112021010794A2 (en) * 2018-12-06 2021-08-31 Dupont Nutrition Biosciences Aps PROBIOTICS FOR COGNITIVE AND MENTAL HEALTH
US20220211774A1 (en) * 2019-05-06 2022-07-07 Dupont Nutrition Biosciences Aps Probiotics for mental health
KR102463809B1 (en) * 2019-05-24 2022-11-04 한국식품연구원 Lactobacillus paracasei wikim0110 having antibacterial activity against clostridioides difficile and composition comprising the same
CN110279119A (en) * 2019-07-23 2019-09-27 河北一然生物科技有限公司 Mixing probiotics Nagqu 4580 (Nagqu 4580) is applied in the food for alleviating depression
IT202000008482A1 (en) * 2020-04-21 2021-10-21 Montefarmaco Otc S P A ORAL COMPOSITION CONTAINING S-ADENOSYL METHIONINE (SAME) AND AT LEAST ONE PROBIOTIC AND ITS USE
EP3932415A1 (en) 2020-07-01 2022-01-05 Fundació Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI) Gut microbiota composition and uses thereof
US20220132902A1 (en) * 2020-08-12 2022-05-05 Pharmavite, Llc Prebiotic composition of pectin, beta-glucan, xylooligosaccharide and/or ashwagandha and a method of improving mood
KR102404657B1 (en) * 2020-09-23 2022-06-07 주식회사 에치와이 Compositions for Preventing, Improving or Treating Cognitive Disorder and Depression
KR102404658B1 (en) * 2020-09-23 2022-06-07 주식회사 에치와이 Compositions for Preventing, Improving or Treating Cognitive Disorder and Depression
KR102404659B1 (en) * 2020-09-23 2022-06-07 주식회사 에치와이 Compositions for Preventing, Improving or Treating Cognitive Disorder and Depression
CN116916942A (en) * 2020-12-17 2023-10-20 欣巴伦斯有限公司 Probiotic compositions and their use in the prevention and/or treatment of stress-related disorders
WO2022224273A1 (en) * 2021-04-21 2022-10-27 Srikant Dr Niriee Novel psychobiotic compositions
EP4104847A1 (en) * 2021-06-16 2022-12-21 Galenus G.H. AG Composition for the treatment of mood disorders
TWI810645B (en) * 2021-09-06 2023-08-01 景岳生物科技股份有限公司 Lactobacillus composition and use thereof for improving anxiety caused by antibiotics
CN114081184B (en) * 2021-11-25 2022-11-11 江苏新申奥生物科技有限公司 Probiotic capable of preventing depression and anxiety behavior formation and application thereof
CN114947135B (en) * 2022-05-17 2023-10-24 江苏艾兰得营养品有限公司 Probiotic composition and preparation for regulating emotion, and preparation method and application thereof
CN116076734B (en) * 2022-10-26 2024-04-26 健码制药（广东）有限公司 Traditional Chinese medicine/probiotic/prebiotic microecological preparation for resisting oxidization and depression and preparation and application thereof
WO2024095199A1 (en) * 2022-11-02 2024-05-10 Probionova Sa Bacterial strains to support the mood and cognitive functionality, compositions and uses thereof
CN116138457A (en) * 2022-12-14 2023-05-23 温州医科大学 Composite nutritional composition with depression symptom relieving effect
CN117965398B (en) * 2024-03-29 2024-06-07 微康益生菌(苏州)股份有限公司 Composite probiotics with mood stabilization effect and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
FR2793257B1 (en) 1999-05-06 2001-07-27 Gervais Danone Sa LACTIC BACTERIA WITH ANXIOLYTIC PROPERTIES, AND USES THEREOF
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US7387796B2 (en) * 2002-01-30 2008-06-17 Hebert Rolland F Stable compositions of S-adenosyl-l-methionine with dextran
KR20040083471A (en) 2002-02-07 2004-10-02 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. Carnitine in the treatment of geriatric depression
JP2004059488A (en) 2002-07-29 2004-02-26 Asahi Food & Healthcare Ltd Lactobacillus intestinal disorder controlling composition and food
US20040265279A1 (en) * 2003-05-08 2004-12-30 Timothy Dinan Probiotics in the treatment of atypical depression and other disorders characterized by hypothalamic pitiuitary-adrenal axis over-activity
JP2011026204A (en) 2007-11-26 2011-02-10 Rei Furukawa Prophylactic and/or therapeutic composition for disease caused by inhalation of tobacco smoke
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
EP2332539A4 (en) 2008-08-21 2012-05-09 Suntory Holdings Ltd Pharmaceutical preparation, food or beverage having inhibitory activity on serotonin transporter
CN102573496B (en) * 2009-07-01 2015-08-26 玛格塞蒂克斯公司 Slow release magnesium composition and uses thereof
PL2467031T3 (en) * 2009-08-18 2015-03-31 Nestec Sa A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.
RU2567009C2 (en) 2010-12-17 2015-10-27 Компани Жервэ Данон Lactococcus lactis STRAIN FOR TREATMENT OR PREVENTION OF DIGESTION DISORDER AND THEREOF APPLICATION
CN103415297A (en) * 2010-12-29 2013-11-27 雀巢产品技术援助有限公司 A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
US20130064803A1 (en) * 2011-09-14 2013-03-14 Naidu Lp BIO-REPLENISHMENT (BioRep) FOR COGNITIVE HEALTH

Also Published As

Publication number Publication date
EP3212191B1 (en) 2022-10-05
AU2015337800B2 (en) 2021-05-27
US11135181B2 (en) 2021-10-05
CA2964971A1 (en) 2016-05-06
CA2964971C (en) 2023-04-11
EP3212191A1 (en) 2017-09-06
NZ731151A (en) 2021-03-26
EP3212191A4 (en) 2018-10-24
US20170312232A1 (en) 2017-11-02
AU2015337800A1 (en) 2017-05-11
ES2929100T3 (en) 2022-11-24
WO2016065419A1 (en) 2016-05-06

Similar Documents

Publication Publication Date Title
SG11201703193XA (en) Treatment for depression and depressive disorders
IL279627A (en) Method for the treatment of depression
IL248856B (en) New treatment
IL250715A0 (en) Compositions and methods for treating proliferation disorders
IL273932A (en) Viral treatment and prophylaxis methods
GB201608885D0 (en) Treatment
GB201522243D0 (en) Treatment
HK1245127A1 (en) Methods and compositions for treating brain diseases
GB201502137D0 (en) Treatment
AP2017009724A0 (en) Methods and compositions for treating hiv-related disorders
GB201508841D0 (en) Treatment
GB201411027D0 (en) Treatment
GB201412010D0 (en) Treatment of hypertransaminasemia
ZA201608775B (en) Hair treatment composition
GB201503008D0 (en) Treatment
AU2014904306A0 (en) Treatment for depression and depressive disorders
GB201617107D0 (en) Treatment
GB201612260D0 (en) Treatment
GB201612193D0 (en) Treatment
GB201609683D0 (en) Treatment
GB201518349D0 (en) Treatment
GB201515739D0 (en) Treatment
GB201514008D0 (en) Treatment
GB201417719D0 (en) New treatment
GB201413317D0 (en) Atheroscierosis treatment